Significant Ownership of James E. Flynn
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for James E. Flynn focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Jonathan Isler - Jonathan Isler, Attorney-in-Fact
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow James E. Flynn and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from James E. Flynn
Significant Ownership of James E. Flynn
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OMIC | Singular Genomics Systems, Inc. | Common Stock, par value $0.0001 per share | 100% | $20,010 | -$4,972,385 | 1,000 | -100% | Deerfield Mgmt IV, L.P. | 21 Feb 2025 |
| LRMR | Larimar Therapeutics, Inc. | Common Stock, par value $0.01 per share | 34% | $123,052,785 | +$17,250,000 | 35,667,474 | +16% | Deerfield Management Company, L.P. | 27 Feb 2026 |
| NUVL | Nuvalent, Inc. | Class A common stock, $0.0001 par value per share | 24% | $2,238,152,303 | -$71,496,004 | 22,852,280 | -3.1% | Deerfield Management Company, L.P. | 31 Dec 2025 |
| PHGE | BiomX Inc. | Common Stock, par value $0.0001 per share | 10% | 989,056 | -94% | Deerfield Management Company, L.P. | 15 Apr 2026 | ||
| AFIB | Acutus Medical, Inc. | Common Stock, par value $0.001 per share | 9.1% | $233,441 | -$179,058 | 5,492,725 | -43% | James E. Flynn | 27 Jan 2025 |
| FHTX | Foghorn Therapeutics Inc. | Common Stock | 8.6% | $24,566,920 | 5,139,523 | Deerfield Mgmt, L.P. | 31 Mar 2026 | ||
| AHCO | AdaptHealth Corp. | Class A Common Stock | 8.5% | $213,579,981 | 23,863,685 | Deerfield Management Company, L.P. | 30 Sep 2025 | ||
| Lomond Therapeutics Holdings, Inc. | Common Stock | 8.4% | 2,692,625 | Deerfield Mgmt, L.P. | 30 Sep 2025 | ||||
| PHGE | BiomX Inc. | Common Stock, par value $0.0001 per share | 8.1% | $1,299,295 | -$144,727 | 889,928 | -10% | Deerfield Management Company, L.P. | 26 May 2026 |
| SPRY | ARS Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share | 7.8% | $134,624,739 | -$18,102,531 | 7,610,217 | -12% | Deerfield Management Company, L.P. | 30 Jul 2025 |
| BCRX | BioCryst Pharmaceuticals, Inc. | Common Stock | 6.8% | $109,278,420 | +$16,550,640 | 14,341,000 | +18% | Deerfield Mgmt, L.P. | 31 Dec 2025 |
| SVRA | Savara Inc. | Common Stock | 6.7% | $48,441,330 | 13,569,000 | Deerfield Mgmt, L.P. | 30 Oct 2025 | ||
| HLXB | BridgeBio Oncology Therapeutics, Inc. | Common Stock | 6.2% | 4,885,446 | Deerfield Management Company, L.P. | 11 Aug 2025 | |||
| COGT | Cogent Biosciences, Inc. | Common Stock | 5.3% | $348,099,826 | -$354,685 | 9,043,903 | -0.1% | Deerfield Mgmt, L.P. | 31 Mar 2026 |
| VERA | Vera Therapeutics, Inc. | Common Stock | 5.2% | $75,299,151 | 3,348,117 | Deerfield Mgmt, L.P. | 06 Jun 2025 | ||
| CGEM | Cullinan Therapeutics, Inc. | Common Stock | 5% | $17,357,187 | 2,927,013 | Deerfield Mgmt, L.P. | 30 Sep 2025 | ||
| DCGO | DocGo Inc. | Common Stock | 5% | $11,214,330 | 5,051,500 | Deerfield Mgmt, L.P. | 13 Feb 2025 | ||
| BKD | Brookdale Senior Living Inc. | Common Stock | 4.9% | $89,721,517 | -$28,721,539 | 11,637,032 | -24% | Deerfield Mgmt, L.P. | 22 Aug 2025 |
| CERT | Certara, Inc. | Common Stock | 4.9% | $88,705,753 | -$25,019,207 | 7,808,605 | -22% | Deerfield Mgmt, L.P. | 25 Nov 2025 |
| EMBC | Embecta Corp. | Common Stock | 4.7% | $32,319,956 | 2,720,535 | Deerfield Mgmt, L.P. | 31 Mar 2025 | ||
| INSP | Inspire Medical Systems, Inc. | Common Stock | 4.5% | $70,212,109 | -$9,714,936 | 1,296,862 | -12% | Deerfield Mgmt, L.P. | 14 May 2026 |
| CALC | CalciMedica Inc. | Common Stock | 4.3% | $4,304,937 | 653,253 | Deerfield Mgmt, L.P. | 06 Feb 2026 | ||
| MNKTQ | Mallinckrodt plc | Ordinary Shares, par value $0.01 per share | 4.1% | 804,259 | Deerfield Management Company, L.P. | 31 Mar 2025 | |||
| ALHC | Alignment Healthcare, Inc. | Common Stock | 3.8% | $129,213,102 | 7,304,302 | Deerfield Mgmt, L.P. | 31 Dec 2024 | ||
| INDV | Indivior PLC | Ordinary Shares, $0.50 nominal value per share | 3.7% | $111,255,547 | -$143,518,681 | 4,614,498 | -56% | Deerfield Mgmt, L.P. | 10 Nov 2025 |
| CPRX | Catalyst Pharmaceuticals, Inc. | Common Stock | 2.6% | $74,033,050 | 3,133,011 | Deerfield Mgmt, L.P. | 31 Dec 2024 | ||
| VTYX | Ventyx Biosciences, Inc. | Common Stock | 0.76% | $673,769 | 534,737 | Deerfield Mgmt, L.P. | 31 Dec 2024 | ||
| OSCR | Oscar Health, Inc. | Class A Common Stock | 0% | $0 | 0 | Deerfield Mgmt, L.P. | 30 Sep 2025 | ||
| OMI | Owens & Minor, Inc. | Common Stock | 0% | $0 | 0 | Deerfield Mgmt, L.P. | 31 Mar 2025 | ||
| PRLD | Prelude Therapeutics Incorporated | Common Stock | 0% | $0 | 0 | Deerfield Mgmt, L.P. | 31 Dec 2024 | ||
| KURA | Kura Oncology, Inc. | Common Stock | 0% | $0 | 0 | Deerfield Mgmt, L.P. | 31 Dec 2024 |
Schedules 13D/G Reported by James E. Flynn:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.